Ledger.Open graph →
SEC Form D · filed September 14, 2021

GLO Pharma, Inc

Offering
$15.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Carlsbad, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Lauren Otsuki · Carlsbad, CADirectorTodd Jackson · Carlsbad, CADirectorCarol Shen · Carlsbad, CADirectorNicole Quinn · Carlsbad, CADirectorScott Glenn · Carlsbad, CAExec · DirectorDerive Ventures GP I, LLC · SAN FRANCISCO, CADirectorTyler Carrico · SAN FRANCISCO, CADirectorJeff Stinson · Little Rock, ARDirectorDan Dearborn · Tampa, FLExec · DirectorMichael Scott · SAN FRANCISCO, CADirectorJacob B. Jones · Raleigh, NCDirectorGordon V. Tucker · Raleigh, NCDirectorJeffrey G. Brock · Raleigh, NCDirectorNicolas T. Giauque · San Francisco, CADirectorSteve Howard · Singapore, U0Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗